Lyra Therapeutics, Inc.
USD0.44
-0.06 (-11.98%)
CEO
Carmichael S. Roberts Jr.
IPO Date
2020-05-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.46
Prev. Close
$0.50
Day Low
$0.44
Day High
$0.48
52W Low
$0.44
52W High
$37.50
Market Cap
$0.00B
Volume
0.08M
| -7.2 |
| 31 Dec 2023 | FY | 100.0% | -4023.1% | -70.1% | -44.0% | 0.30 | 5.35 | -207.9 |
| 31 Dec 2022 | FY | 100.0% | -4055.6% | -68.5% | -50.3% | 0.05 | 6.97 | -85.9 |
| 31 Dec 2021 | FY | -10318.9% | -15267.7% | -126.8% | -79.3% | 0.04 | 2.63 | -65.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -29.7% | -27.4% | 0.03 | 15.54 | -220.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -222.5% | -109.0% | 0.45 | 1.94 | -465.7 |
| 31 Dec 2018 | FY | 100.0% | -484.6% | 5.6% | -23.8% | 0.00 | 12.72 | -964.6 |
| -0.5 |
| 30 Jun 2025 | Q2 | -9.3% | -4063.9% | -458.5% | -14.1% | 20.02 | 2.78 | -0.4 |
| 31 Mar 2025 | Q1 | 100.0% | -4670.5% | -220.7% | -15.2% | 8.61 | 2.96 | -12.2 |
| 31 Dec 2024 | Q4 | 100.0% | -5253.1% | -94.7% | -16.5% | 2.97 | 3.41 | -15.3 |
| 30 Sept 2024 | Q3 | 100.0% | -6088.7% | -57.6% | -15.1% | 1.71 | 3.64 | -17.7 |
| 30 Jun 2024 | Q2 | 100.0% | -8048.7% | -155.4% | -50.9% | 1.19 | 3.60 | -5.0 |
| 31 Mar 2024 | Q1 | 74.4% | -4220.3% | -29.0% | -15.9% | 0.49 | 4.78 | -222.7 |
| 31 Dec 2023 | Q4 | 41.8% | -10380.8% | -16.9% | -10.6% | 0.30 | 5.35 | -264.6 |
| 30 Sept 2023 | Q3 | -2173.5% | -2877.0% | -18.6% | -13.0% | 0.07 | 5.45 | -177.9 |